Apnimed's OSA drug NDA accepted by FDA, PDUFA date set for February 2027Sep 8Quarterly updateAD109Apnimed
FDA accepts Axsome's NDA for AXS-12 in narcolepsy cataplexyJul 15Regulatory milestoneAxsome Therapeutics, Inc.
Sign inSign in